{
    "nctId": "NCT04437602",
    "briefTitle": "Added Value of Preoperative Contrast Enhanced Mammography in Staging of Malignant Breast Lesions",
    "officialTitle": "Added Value of Preoperative Contrast Enhanced Mammography (PROCEM) in Staging of Malignant Breast Lesions - a Prospective Randomized Multicenter Trial",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 441,
    "primaryOutcomeMeasure": "Rate of patients with change of primary treatment due to findings at additional CEM",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Planned primary surgery for suspicious or verified breast malignancy Age of 18 years and above Signed informed consent\n\nExclusion Criteria:\n\n* Planned neoadjuvant therapy On-going pregnancy Iodinated contrast agent allergy Renal failure (abnormal S-creatinine) Untreated thyreotoxicosis Severe heart failure Myastenia gravis Breast implant Local recurrence as index lesion Inability to understand and comprehend oral and written information of the study",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}